Case Study: AstraZeneca boosts rep engagement and HCP education with ACTO

ACTO, Axiom, and AstraZeneca Set a New Benchmark For Provider Partnerships in the Life Sciences Industry With the Triple A Initiative

The customer, AstraZeneca, needed to launch a new indication for a diabetes drug and faced the challenge of equipping a large number of sales representatives to effectively and compliantly educate healthcare professionals. To address this, AstraZeneca partnered with vendors ACTO and Axiom to form the Triple A Initiative, leveraging ACTO's field engagement and insights platform.

The solution implemented by ACTO and Axiom consolidated content creation, delivery, and field insights into a single, mobile-first offering. This included microlearning content and actionable data analytics. The results for AstraZeneca included a significant increase in rep engagement with over 5,000 content pulls, more effective conversations with healthcare professionals, and the establishment of a data-driven culture for continuous program improvement.

AstraZeneca